It is not all a bed of roses on the Nootropic / Smart Drug front my soon to be well informed friends. There is plenty of information that we do not know and plenty of testing that needs to be done.
I have been a consumer of Nootropics for several years with my consumption picking up, by about 50%, over the last six months. In my case I have seen substantial improvements in several areas. Most noticeably is my memory — where once I struggled to remember what I did yesterday, I’m finding it relatively easy to picture several days of history, clearly. Read my story here.
Additionally my energy levels have increased, due in part to my exercise regime that I started about 12 months back and the specialized nootropics. Simply take a look at some of the advertisements on this site and you’ll know which ones I’m talking about.
I often wonder if I’m doing more harm than good with the capsules and powders I’m taking. So I started a new quest. I’ve broadened the scope of this site and my social media sites to cover the good and the bad about Nootropics and Smart Drugs.
Water, taken in moderation, cannot hurt anybody. – Mark Twain
Let’s make it a point to follow Mark Twain’s advice and those of us who may be gung-ho and trying everything and anything … even if the label looks cool! How about we pull the reins back a bit, read the following articles I’ve gathered and get a better understanding of where we are with cognitive enhancing pills and nootropic supplements.
I am not advocating abstinence. I am going to continue my nootropic routine — I know exactly what I am taking and the exact dosage (the benefit of using nootropics from a company that tells you to ask for their CofA!). What I am advocating is looking at what we are consuming with a focused lens.
Brain-Enhancing ‘Smart Drugs’ Are Going Commercial | Motherboard
As the demand for cognitive enhancements expands, nootropics have grown from the stuff of internet-driven self-experimentation to an expanding sector in the massive supplements market.
Over the past year, Facebook users may have done a double take on seeing ads for Alleradd, a cognitive enhancement pill that sounds a lot like the prescription drug Adderall.
Alleradd promises users the same kinds of effects that have made the similarly-named ADHD medication a black market blockbuster on college campuses and in high pressure workplaces across the country.
“Alleradd elevates your energy, enhances your memory, and helps you find your focus, even if you are tired or stressed out,” explains the website for the product.
But while amphetamine-based Adderall is a controlled substance legally available only by prescription, Alleradd is marketed as a nutritional supplement and available online to anyone with a valid credit card.
It’s one of an increasingly popular, if controversial class of drugs and supplements called nootropics that are designed to boost memory, attention span and cognitive function, even in people with otherwise healthy brains. And as the demand for cognitive enhancements expands, nootropics have grown from the stuff of internet-driven self-experimentation to an expanding sector in the massive supplements market. Brain-Enhancing ‘Smart Drugs’ Are Going Commercial | Motherboard
Aussies taking dangerous smart drugs to get ahead | The New Daily
Australians have begun dabbling, perhaps illegally, in potentially brain-enhancing drugs that do not have the support of mainstream medicine.
A host of websites targeted at Australian consumers purport to sell ‘nootropics’ – drugs that reportedly give users a cognitive boost.
The New Daily understands one of the most popular of these is Modafinil, a prescription medicine normally given to those with narcolepsy and sleep apnea to help them stay awake. Aussies taking dangerous smart drugs to get ahead | The New Daily
The Dangers And Benefits Of Cognitive-Enhancing Drug Use In Healthy People
What are the harms and benefits of long-term use of cognitive-enhancing drugs by healthy individuals?
No one can say, but they are popular.
There is growing ‘lifestyle use’ of cognitive-enhancing drugs – such as methylphenidate (Ritalin) and modafinil (Provigil) – by healthy individuals to improve concentration, memory, and other aspects of cognitive performance.
But very little is known about the long-term effects of this non-medical use, say the authors.
No one even knows how many healthy people are using cognitive-enhancing drugs, in what ways and why.
What evidence there is suggests that healthy individuals use cognitive-enhancing drugs to gain a competitive edge at school, university, or work, and for maintaining attention and performance when sleep derived or jet lagged.
Most research has focused on student use in the USA with estimates varying between 5% and 35%.
This might only be the tip of the iceberg and is unlikely to be representative of usage in professional or older populations.Government, the pharmaceutical industry, and national medical organizations need to work together to find out, say neuroscientists Professor Barbara Sahakian and Dr. Sharon Morein-Zamir from the University of Cambridge in The Lancet Psychiatry.
A wide range of pharmaceutical substances from psychotropic medications to nicotine and caffeine are used by patients and healthy individuals to alter, improve, and enhance mental functioning.
Most cognitive enhancers, such as modafinil and donepezil, have been developed by the pharmaceutical industry to treat the effects of impaired cognition in conditions such as Alzheimer’s disease, attention deficit hyperactivity disorder (ADHD), and schizophrenia. The Dangers And Benefits Of Cognitive-Enhancing Drug Use In Healthy People
Humans: The Next Platform | TechCrunch
Biohacking and transhumanist advances (including nootropics, extended longevity, cybernetic implants, better behavioral and genetic self-understanding) will materially advance our quality of life and productivity in the coming decade, but we need to be thoughtful about the potential social and ethical pitfalls as we transform.
Google Trends shows a marked uptick in searches for “nootropics” and related biohacking fields, so now is the time to have the conversation about the direction we’re headed.
Digital products and companies are not just changing the way we live our lives, but also playing larger and more influential roles in public policy and governance. This trend of the technology industry driving broader social policy will perhaps be even greater with biohacking companies as their product innovations begin to alter and transform what it means to be human.
Biohacking is simply the next frontier in the drive to better ourselves. People will enhance themselves physically to have better bones, better eyes and better resilience to disease, as well as attain an overall better standard of living. More people will have access to their full potential.
However from an ethics perspective, there’s already worrying concerns about the widening socio-economic gap around the world today; there’s an argument that when only the wealthy have access, it further separates the haves from the have-nots.
Bill McKibben, a prominent critic of a hyper-segregated, Gattaca-esque version of the future, cautions that biohacking technologies like genetic enhancement “would take the gap in power, wealth, and education that currently divides both our society and the world at large, and write that division into our very biology.”
From a technology perspective, this bifurcation story just hasn’t played out. Over and over again, we’ve seen new technologies popularize and achieve economies of scale, and then quickly drop in price and diffuse across all levels of society.
Increasing market demand leads to new research and production techniques that in the long run drive down the price of fundamentally useful new devices and technologies. 23andMe initially provided genetic reports for $299, and within several years were able to cut its price by two-thirds.
Research into nootropics and other biometric and bio-enhancement technologies requires significant R&D investment and innovative new methods of production and distribution. The cutting edge of any tech is expensive, but prices come down with time.
Biohacking companies should follow the examples of Google Loon and Facebook’s Internet.org, bringing basic technologies to the world as a service to society, democratizing access and encouraging participation in the commerce of the future. Humans: The Next Platform | TechCrunch